Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR GBP Hedged (D) | PRUB

Register to Unlock Ratings
Performance History30/04/2024
Growth of 1,000 (GBP) Advanced Graph
Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR GBP Hedged (D)
          | 
          PRUB
Fund-----2.7
+/-Cat-----
+/-B’mrk-----
 
Key Stats
Closing Price
03/05/2024
 GBX 1036.80
Day Change 0.77%
Morningstar Category™ Other Bond
Volume 0
Exchange LONDON STOCK EXCHANGE, THE
ISIN LU2621112452
Fund Size (Mil)
02/05/2024
 USD 85.75
Share Class Size (Mil)
02/05/2024
 GBP 33.38
Ongoing Charge
30/08/2023
  0.07%
Investment Objective: Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR GBP Hedged (D) | PRUB
To track the performance of Solactive USD Investment Grade Corporate Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index.
Returns
Trailing Returns (GBP)02/05/2024
YTD-1.94
3 Years Annualised-
5 Years Annualised-
10 Years Annualised-
12 Month Yield -
Dividend Paying Frequency Annually
Management
Manager Name
Start Date
-
-
Inception Date
11/07/2023
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Solactive USD IG Corp TR USD-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Amundi Index Solutions - Amundi Prime US Corporates UCITS ETF DR GBP Hedged (D) | PRUB29/04/2024
Fixed Income
Effective Maturity11.10
Effective Duration6.98
Morningstar Style Box®
Fixed Income Style
Asset Allocation
  % Long% Short% Net Assets
Stock0.000.000.00
Bond99.790.0099.79
Property0.000.000.00
Cash0.000.000.00
Other0.210.000.21

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures